(Q40472425)

20 September 2017

1 reference

title

Drug-Induced Metabolic Bone Disease (English)

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

23 July 2024

author name string

M. Wolinsky-Friedland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7656896

23 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7656896

23 July 2024

publication date

1 June 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:S088985291830046X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

https://api.elsevier.com/content/article/PII:S088985291830046X?httpAccept=text/plain

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Endocrinology and Metabolism Clinics of North America

23 July 2024

published in

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

395-420

1 reference

Corticosteroid-induced osteoporosis

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Steroid-induced fractures and bone loss in patients with asthma

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone mineral density in postmenopausal women treated with L-thyroxine

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Risk factors for postmenopausal osteoporosis

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Mineral and bone metabolism in thyroid disease: a review

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Heparin-Induced Osteopenia: An Appraisal

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Detrimental skeletal effects of thyrotropin suppressive doses of thyroxine: fact or fantasy?

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The osteoporosis of heparinotherapy and systemic mastocytosis

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Smoking and estrogen-related disease

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Demonstration that ethanol inhibits bone matrix synthesis and mineralization in the rat

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone disease in alcohol abuse.

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The Effect of Anticonvulsant Therapy on Serum Levels of 25-Hydroxy-Vitamin D, Calcium, and Parathyroid Hormone

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Fractures in Still's disease

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Influence of 1 alpha-(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Is long-term levothyroxine therapy safe?

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Ionized and total serum calcium and parathyroid hormone in hyperthyroidism

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Na+-K+-activated adenosine triphosphatase and intestinal electrolyte transport. Effect of adrenal steroids

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Glucocorticoid Potentiation of the Adenosine 3′,5′- Monophosphate Response to Parathyroid Hormone in Cultured Rat Bone Cells*

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Cortisol decreases bone formation by inhibiting periosteal cell proliferation

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Stimulation of bone formation by prostaglandin E2

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Osteomalacia and bone disease arising from aluminum

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone loss in hypothyroidism with hormone replacement. A histomorphometric study

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Alkaline Phosphatase Isoenzyme Patterns in Hyperthyroidism

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Vertebral fractures resulting from prolonged cortisone and corticotropin therapy

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of Glucocorticoids on Fetal Rat Bone Collagen Synthesis in Vitro*

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone histomorphometry in glucocorticoid-induced osteoporosis

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Thyrotoxic bone disease in women: a potentially reversible disorder

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of diphenylhydantoin on synthesis of collagen and noncollagen protein in tissue culture

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Trabecular bone remodeling and bone balance in hyperthyroidism

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Exogenous hyperthyroidism with osteoporosis

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Intestinal Calcium-Binding Protein and Calcium Absorption in Cortisol-Treated Chicks: Effects of Vitamin D3and 1,25-Dihydroxyvitamin D3*

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Cytoplasmic glucocorticoid binding proteins in bone cells

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Tamoxifen protects against steroid-induced bone loss

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Long-term thyroxine treatment and bone mineral density

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effect of Glucocorticoids on Function of the Parathyroid Glands in Man

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Gonadal consequences of alcohol abuse: lessons from the liver

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of prednisone and deflazacort on vertebral bone mass

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Osteomalacia Accompanying Chronic Anticonvulsant Therapy

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The effect of chronic caffeine administration on serum markers of bone mineral metabolism and bone histomorphometry in the rat.

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The effects of heparin and protamine on resorption of bone particles

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effect of short-term glucocorticoids on serum osteocalcin in healthy young men.

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy.

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone complications of anticonvulsants

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Phenobarbital-induced alterations in vitamin D metabolism

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Cortisol enhancement of PTH-stimulated cyclic AMP accumulation in cultured fetal rat long bone rudiments

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man.

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effect of phenobarbital administration on the subcellular distribution of vitamin D3-3H in rat liver

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Interaction of Diphenylhydantoin (Phenytoin) and Phenobarbital with Hormonal Mediation of Fetal Rat Bone Resorption In Vitro

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Serum dihydroxyvitamin D metabolite concentrations in patients on chronic anticonvulsant drug therapy: response to pharmacologic doses of vitamin D2

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Cortisol modulation of osteoblast metabolic activity in cultured neonatal rat bone

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Long-term therapy with subcutaneous heparin during pregnancy

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

L-thyroxine dosage: a reevaluation of therapy with contemporary preparations

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Roentgenologic changes of the skeletal system in Cushing's syndrome

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

MULTIPLE FRACTURES ASSOCIATED WITH LONG-TERM SODIUM HEPARIN THERAPY

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Osteoporosis of the slender smoker revisited by epidemiologic approach

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause

23 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Clinical indications for bone mass measurements. A report from the Scientific Advisory Board of the National Osteoporosis Foundation

23 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effect of diphenylhydantoin on the metabolism of dexamethasone

23 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results

23 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose

23 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Decreased bone density in hyperprolactinemic women

23 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Influence of Diphenylhydantoin and Phenobarbital on Intestinal Calcium Transport in the Rat

23 July 2024

108

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Etidronate disodium in the treatment of Paget's disease of bone

23 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment

23 July 2024

110

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Nonhemorrhagic complications of anticoagulant therapy

23 July 2024

114

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Fluoride and bone--quantity versus quality.

23 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone loss in response to long-term glucocorticoid therapy

23 July 2024

116

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone loss after glucocorticoid therapy

23 July 2024

117

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease

23 July 2024

118

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

23 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment

23 July 2024

122

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Reduction of serum testosterone levels during chronic glucocorticoid therapy

23 July 2024

123

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Cigarette smoking and urinary estrogens

23 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Radiologic aspects of glucocorticoid-induced bone disease

23 July 2024

125

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Renal bone disease 1990: an unmet challenge for the nephrologist

23 July 2024

126

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Disturbed mineral metabolism in hyperthyroidism: good correlation with tri-iodothyronine

23 July 2024

127

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Smoking and age at menopause in women

23 July 2024

133

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Influence of aging and induction of rat liver and kidney microsomal mixed function oxidase systems

23 July 2024

134

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking

23 July 2024

140

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Glucocorticoid-induced osteoporosis: mechanisms for bone loss; evaluation of strategies for prevention

23 July 2024

141

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism

23 July 2024

144

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism

23 July 2024

145

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

23 July 2024

146

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Corticosteroids and osteoporosis

23 July 2024

148

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis

23 July 2024

149

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss

23 July 2024

151

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.

23 July 2024

153

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Recovery from steroid-induced osteoporosis

23 July 2024

154

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of tobacco use on axial and appendicular bone mineral density

23 July 2024

155

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of theophylline and salbutamol on phosphate and calcium metabolism in normal subjects

23 July 2024

156

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Local and systemic factors in the pathogenesis of osteoporosis

23 July 2024

157

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Regulation of bone formation (second of two parts).

23 July 2024

158

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Pathogenesis and treatment of steroid osteoporosis

23 July 2024

159

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

23 July 2024

160

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Low serum osteocalcin levels in glucocorticoid-treated asthmatics

23 July 2024

161

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy

23 July 2024

162

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics

23 July 2024

163

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria

23 July 2024

164

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography

23 July 2024

165

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Bone mineral density and thyroid hormone therapy

23 July 2024

166

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration

23 July 2024

168

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Mineral loss in cortical and trabecular bone during high-dose prednisone treatment

23 July 2024

169

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

23 July 2024

170

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Involutional osteoporosis

23 July 2024

171

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis

23 July 2024

172

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Salmon calcitonin in the therapy of corticoid-induced osteoporosis

23 July 2024

173

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor

23 July 2024

174

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Development of anticonvulsant osteomalacia in epileptic patients on phenytoin treatment

23 July 2024

175

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism

23 July 2024

176

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine

23 July 2024

177

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects

23 July 2024

179

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Inhibition of Luteinizing Hormone Secretion Induced by Synthetic LRH by Long-term Treatment with Glucocorticoids in Human Subjects

23 July 2024

180

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Corticosteroid effects on proximal femur bone loss

23 July 2024

181

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids

23 July 2024

182

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition

23 July 2024

184

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess

23 July 2024

185

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Differential effects of endocrine dysfunction on the axial and the appendicular skeleton

23 July 2024

186

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Hydroxyproline excretion in the urine and calcium metabolism during long-term treatment of thyrotoxicosis with propylthiouracil

23 July 2024

188

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Long-term therapy of Paget's disease of bone with EHDP

23 July 2024

189

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The interaction of parathyroid hormone and aluminum in renal osteodystrophy

23 July 2024

190

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Cigarette smoking, obesity, and bone mass

23 July 2024

191

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Heparin-Induced Spinal Fractures

23 July 2024

193

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine

23 July 2024

194

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs

23 July 2024

195

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy

23 July 2024

197

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The effect of thyroxine administration on intestinal calcium absorption and calcium binding protein activity in the chick

23 July 2024

198

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

The effect of a new vitamin D analog, 22-oxa-1 alpha,25(OH)2D3, on bone mineral metabolism in normal male rats

23 July 2024

199

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Different actions of vitamin D2 and D3 on bone metabolism in patients treated with phenobarbitone/phenytoin

23 July 2024

200

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

23 July 2024

Thyroxine therapy

201

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Effects of tamoxifen on spinal bone density in women with breast cancer

23 July 2024

204

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Inhibition of collagen and sulfated glycosaminoglycan synthesis in neonatal mouse dermal fibroblasts by corticosterone

23 July 2024

205

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids

23 July 2024

206

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Long-term anticonvulsant therapy and intestinal calcium absorption

23 July 2024

207

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment

23 July 2024

208

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

Heparin-induced osteopenia in pregnancy

23 July 2024

210

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30046-X

23 July 2024

Identifiers

1 reference